Sterling Biotech reports standalone net loss of Rs 109.50 crore in the June 2017 quarter

Sales decline 0.06% to Rs 94.82 crore

Net Loss of Sterling Biotech reported to Rs 109.50 crore in the quarter ended June 2017 as against net loss of Rs 87.54 crore during the previous quarter ended June 2016. Sales declined 0.06% to Rs 94.82 crore in the quarter ended June 2017 as against Rs 94.88 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales94.8294.88 0 OPM %0.5311.60 -PBDT-100.77-67.63 -49 PBT-167.45-133.87 -25 NP-109.50-87.54 -25

Powered by Capital Market - Live News